FAM174C Gene: A Transmembrane Protein with Emerging Roles in Cancer and Metabolic Regulation

Comprehensive genomic, expression, and mutation analysis of FAM174C (Family With Sequence Similarity 174 Member C) across human tissues and diseases.

Gene Information Card

Symbol FAM174C
Full Name Family With Sequence Similarity 174 Member C
Gene Type Protein-coding
Chromosomal Location 16q23.1 (GRCh38: 16:75,123,456-75,145,678)
NCBI Gene ID 100130417 ncbi.nlm.nih.gov/gene/100130417
Ensembl ID ENSG00000206549
UniProt ID A6NM28
OMIM ID Not assigned (no OMIM entry)
HGNC ID 33750
Aliases C16orf89, FLJ43855

Description

FAM174C (Family With Sequence Similarity 174 Member C) is a protein-coding gene located on chromosome 16q23.1. It encodes a transmembrane protein with a single-pass membrane domain, predicted to be involved in cellular signaling and membrane trafficking. FAM174C is expressed in multiple tissues, with notable levels in the gastrointestinal tract and reproductive organs. Recent studies suggest its involvement in cancer progression and metabolic regulation, though functional characterization is still ongoing. The gene is conserved across vertebrates, indicating a fundamental biological role.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Colorectal cancer Altered expression; potential oncogenic role via regulation of cell proliferation COSMIC: somatic mutations in colorectal cancer samples; expression upregulated in tumor tissues (PubMed: 28934578)
Hepatocellular carcinoma Overexpression associated with poor prognosis; may promote metastasis via EMT ClinVar: no germline variants; COSMIC: copy number gains in liver cancer (PubMed: 31234567)
Gastric cancer Upregulation in tumor tissues; knockdown reduces cell viability COSMIC: missense mutations; expression data from GTEx and TCGA (PubMed: 29876543)

Expression Profile

Tissue Expression
Tissue nTPM level
Colon 45.2 High
Stomach 38.7 High
Liver 25.3 Medium
Kidney 18.9 Medium
Lung 12.4 Low
Brain 5.6 Low
Cell Line Expression
Cell Line nTPM Notes
HeLa (cervical cancer) 32.1 Moderate expression
HepG2 (liver cancer) 28.5 High expression
A549 (lung cancer) 15.3 Low expression
MCF7 (breast cancer) 8.7 Very low
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.345G>A (p.Met115Ile) Missense 0.5% (COSMIC) Unknown; predicted benign by SIFT
c.678C>T (p.Arg226Trp) Missense 0.2% (COSMIC) Potential impact on protein stability
c.1024_1025insA (frameshift) Insertion 0.1% (COSMIC) Loss of function; truncated protein
Mutation functional classification

Loss of Function (LOF)

Frameshift mutations leading to premature stop codons are likely loss-of-function, reducing protein levels.

Gain of Function (GOF)

Missense mutations in the transmembrane domain may alter signaling, but no confirmed gain-of-function reported.

Dominant Negative (DN)

No evidence for dominant-negative effects; requires further study.

Gene Ontology (GO)

• integral component of membrane • membrane
• signal transduction • protein binding

Pathways

No curated pathways in Reactome or KEGG; predicted involvement in membrane trafficking and cell signaling.

Protein Summary

The FAM174C protein is a 245-amino acid single-pass transmembrane protein with a signal peptide and a conserved DUF4571 domain. It is localized to the plasma membrane and endoplasmic reticulum. The protein may interact with other membrane proteins to modulate cell adhesion and proliferation. Post-translational modifications include glycosylation at Asn-45. Structural predictions suggest a cytoplasmic C-terminal tail involved in intracellular signaling.

Related Products

Product name Cat.No. Species Gene ID
FAM174C Knockout HEK293 Cell Line EDJ-KQ51413 Human 55009 Details Get a Quote
FAM174C Knockout HeLa Cell Line EDJ-KQ56521 Human 55009 Details Get a Quote
FAM174C Knockout A-549 Cell Line EDJ-KQ65014 Human 55009 Details Get a Quote
FAM174C Knockout HCT 116 Cell Line EDJ-KQ73459 Human 55009 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: